BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22377847)

  • 1. Expression levels of microRNA-375 in colorectal carcinoma.
    Dai X; Chiang Y; Wang Z; Song Y; Lu C; Gao P; Xu H
    Mol Med Rep; 2012 May; 5(5):1299-304. PubMed ID: 22377847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression levels of microRNA-375 in pancreatic cancer.
    Song S; Zhou J; He S; Zhu D; Zhang Z; Zhao H; Wang Y; Li D
    Biomed Rep; 2013 May; 1(3):393-398. PubMed ID: 24648956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of miR-148b in ovarian carcinoma and its clinical significance.
    Chang H; Zhou X; Wang ZN; Song YX; Zhao F; Gao P; Chiang Y; Xu HM
    Mol Med Rep; 2012 May; 5(5):1277-80. PubMed ID: 22344713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
    Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
    Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
    Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
    Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer].
    Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer.
    Chen WS; Leung CM; Pan HW; Hu LY; Li SC; Ho MR; Tsai KW
    Oncol Rep; 2012 Sep; 28(3):1069-76. PubMed ID: 22766685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.
    Catela Ivkovic T; Aralica G; Cacev T; Loncar B; Kapitanovic S
    Exp Mol Pathol; 2013 Feb; 94(1):148-54. PubMed ID: 23178825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
    Nishida N; Yokobori T; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Kuwano H; Mori M
    Int J Oncol; 2011 May; 38(5):1437-43. PubMed ID: 21399871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
    Tsang WP; Ng EK; Ng SS; Jin H; Yu J; Sung JJ; Kwok TT
    Carcinogenesis; 2010 Mar; 31(3):350-8. PubMed ID: 19926638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages.
    Xiong Y; Zhang YY; Wu YY; Wang XD; Wan LH; Li L; Zhou LM
    Life Sci; 2014 Jun; 106(1-2):19-24. PubMed ID: 24780321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.
    Chiang Y; Song Y; Wang Z; Chen Y; Yue Z; Xu H; Xing C; Liu Z
    J Gastrointest Surg; 2011 Jan; 15(1):63-70. PubMed ID: 21063914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.
    Kulda V; Pesta M; Topolcan O; Liska V; Treska V; Sutnar A; Rupert K; Ludvikova M; Babuska V; Holubec L; Cerny R
    Cancer Genet Cytogenet; 2010 Jul; 200(2):154-60. PubMed ID: 20620599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.
    Bandrés E; Cubedo E; Agirre X; Malumbres R; Zárate R; Ramirez N; Abajo A; Navarro A; Moreno I; Monzó M; García-Foncillas J
    Mol Cancer; 2006 Jul; 5():29. PubMed ID: 16854228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
    Huang Z; Huang S; Wang Q; Liang L; Ni S; Wang L; Sheng W; He X; Du X
    Cancer Res; 2011 Apr; 71(7):2582-9. PubMed ID: 21427358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.